Home / Inspections / 1046065

FDA Inspection 1046065 — Medefil Incorporated

Medefil Incorporated — FEI 3001677091

The FDA completed an inspection of Medefil Incorporated on March 29, 2018 in Glendale Heights, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 29, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Glendale Heights, IL (United States)

Facility

Other inspections at this facility

  • 1251304 (VAI Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 976257 (VAI Fri Jun 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 894968 (VAI Mon Sep 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 808935 (VAI Thu Dec 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 796372 (NAI Wed Aug 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources